Autism Spectrum Disorder & Polygraph Testing: Guide

What Is ASD and How Common Is It?

Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by differences in social communication, social interaction, and patterns of restricted or repetitive behavior, interests, or activities. According to the latest CDC data published in April 2025, approximately 1 in 31 (3.2%) of children aged 8 years in the United States has been identified with ASD — up from the previously reported 1 in 36 — making it one of the most prevalent developmental conditions [1]Verified Data and Statistics on Autism Spectrum Disorder
Confirms latest CDC prevalence of 1 in 31 children (3.2%) identified with ASD from 2022 ADDM Network data, published April 2025. ASD is over 3 times more common among boys than among girls [1]Verified Data and Statistics on Autism Spectrum Disorder
Confirms latest CDC prevalence of 1 in 31 children (3.2%) identified with ASD from 2022 ADDM Network data, published April 2025.

A 2020 CDC-funded study by Dietz et al., published in the Journal of Autism and Developmental Disorders, estimated that approximately 2.21% of U.S. adults — roughly 5.4 million people aged 18–84 — are living with ASD [2]Verified National and State Estimates of Adults with Autism Spectrum Disorder
Confirms estimated 2.21% or 5,437,988 U.S. adults aged 18-84 living with ASD in 2017, with state prevalence ranging from 1.97% to 2.42%. This figure was derived using Bayesian hierarchical modeling applied to existing childhood prevalence data, adjusted for mortality rates. State-level estimates ranged from 1.97% in Louisiana to 2.42% in Massachusetts [2]Verified National and State Estimates of Adults with Autism Spectrum Disorder
Confirms estimated 2.21% or 5,437,988 U.S. adults aged 18-84 living with ASD in 2017, with state prevalence ranging from 1.97% to 2.42%.

The "spectrum" designation is critical to understanding ASD in the context of polygraph testing. Autism manifests with enormous variability across individuals. The DSM-5 classifies ASD by three support levels: Level 1 ("Requiring Support"), Level 2 ("Requiring Substantial Support"), and Level 3 ("Requiring Very Substantial Support"). For polygraph examiners, understanding this spectrum nature is foundational — an examiner cannot apply a one-size-fits-all approach based on an ASD diagnosis alone.

Core Features of ASD Relevant to Polygraph Testing

Several hallmark features of ASD interact directly with the physiological and psychological mechanisms that polygraph testing relies upon:

Social communication differences: Difficulty with pragmatic language, reading social cues, understanding implied meanings, and interpreting non-literal language. This fundamentally affects how an examinee understands and responds to polygraph questions.

Restricted and repetitive behaviors: Including rigid adherence to routines and distress when expectations are disrupted. The unfamiliar polygraph testing procedure itself can trigger significant anxiety responses.

Sensory processing differences: Hyper- or hypo-sensitivity to sensory input including touch, sound, light, and temperature. The physical components of the polygraph — pneumograph tubes, blood pressure cuff, finger electrodes — all create direct sensory challenges.

Executive function differences: Challenges with cognitive flexibility, working memory, and managing shifting demands, which affect the examinee's ability to engage with the multi-phase structure of a polygraph examination.

Alexithymia: Difficulty identifying and describing one's own emotions. According to a systematic review and meta-analysis published in the European Journal of Psychiatry, prevalence rates of alexithymia in ASD groups ranged from 33.3% to 63%, with a weighted mean prevalence rate of 49.93% [6]Verified Investigating alexithymia in autism: A systematic review and meta-analysis
Confirms weighted mean prevalence of alexithymia in ASD at 49.93%, with individual studies ranging from 33.3% to 63%. The commonly cited range of 40–65% is well supported in the literature [7]Verified Alexithymia in Autism Spectrum Disorder
Confirms around 40-65% of people with ASD have high levels of alexithymia, citing Bird & Cook. This has direct implications for how emotional states translate to physiological responses during testing. For more on how mental health conditions interact with polygraph testing, see our guide to OCD and polygraph testing.

The Standard Polygraph Process

To understand why ASD presents such significant challenges for polygraph testing, it helps to review the fundamental mechanisms of the polygraph. A standard polygraph examination typically lasts between 90 minutes and three hours, consisting of several distinct phases. For a full explanation, see our complete guide to lie detector testing.

During the pre-test interview, the examiner establishes rapport, explains the testing process, reviews the test questions, and gathers background information. This phase is critical for establishing psychological readiness. For individuals with ASD, this phase is where the first significant challenges emerge — social communication demands, unfamiliar interpersonal dynamics, and the need to process complex verbal instructions. Learn more about the importance of this phase in our guide to pretest practices in polygraph examinations.

The in-test (data collection) phase involves attaching physiological sensors and asking a series of carefully structured questions while monitoring: respiration (via pneumograph tubes), electrodermal activity (via finger electrodes measuring skin conductance), and cardiovascular activity (via blood pressure cuff). The fundamental premise is that deceptive responses produce involuntary physiological changes — typically increased sympathetic nervous system arousal — that differ from responses to truthful answers. For a deeper understanding of question formats used, visit our guide to polygraph test formats.

The comparison question test (CQT) technique, which forms the basis of most modern polygraph examinations, relies on examiners comparing physiological reactions to relevant questions against reactions to comparison questions. Understanding the psychophysiological basis of the CQT is essential for appreciating why ASD creates such unique challenges.

Every aspect of this process — from the social interaction demands of the pre-test interview to the sensory requirements of sensor attachment to the physiological assumptions underlying the scoring — presents potential complications when the examinee is on the autism spectrum.

Sympathetic Nervous System Dysregulation

The autonomic nervous system (ANS) is the engine that drives polygraph detection. The entire premise of polygraph testing depends on measurable changes in autonomic function — specifically, sympathetic nervous system activation in response to psychologically significant stimuli. For individuals with ASD, this engine operates differently in several well-documented ways.

ASD symptoms have been proposed to be linked to autonomic nervous system atypical functioning, in particular sympathetic hyper-arousal and parasympathetic under-activation [3]Verified Autonomic Disequilibrium at Rest in Autistic Children and Adults
Confirms ASD linked to sympathetic hyper-arousal and parasympathetic under-activation; cites Arora et al. (2021) finding 83% of cardiac autonomic studies point toward hyper-arousal in ASD. In their meta-analysis, Arora et al. (2021) reported that 83% of studies using cardiac autonomic indices point towards a hyper-arousal state in ASD [3]Verified Autonomic Disequilibrium at Rest in Autistic Children and Adults
Confirms ASD linked to sympathetic hyper-arousal and parasympathetic under-activation; cites Arora et al. (2021) finding 83% of cardiac autonomic studies point toward hyper-arousal in ASD. This means that before any polygraph question is asked, an autistic examinee may already have elevated skin conductance levels, faster heart rate, and altered respiratory patterns compared to neurotypical baselines.

This elevated baseline creates a fundamental problem for polygraph scoring. Standard polygraph techniques rely on detecting phasic changes — momentary fluctuations from baseline in response to specific questions. When the baseline itself is already elevated or highly variable, the signal-to-noise ratio deteriorates. Small, meaningful changes in response to relevant questions may be obscured by the already-elevated autonomic state.

A landmark systematic review and meta-analysis by Alvares, Quintana, Hickie, and Guastella (2016) published in the Journal of Psychiatry & Neuroscience confirmed substantial reductions in heart rate variability across psychiatric disorders, highlighting ANS dysfunction as a widespread neurobiological feature [8]Verified Autonomic nervous system dysfunction in psychiatric disorders and the impact of psychotropic medications: A systematic review and meta-analysis
Confirms substantial reductions in HRV across psychiatric disorders (Hedges g = -0.583), establishing ANS dysfunction as a neurobiological feature relevant to polygraph testing. This research has clear relevance to polygraph testing with ASD populations.

Electrodermal Activity and Cardiovascular Differences

Electrodermal activity (EDA) is considered one of the most diagnostically useful physiological channels in polygraph testing. However, research on EDA in autism reveals significant atypicalities. Some autistic individuals show diminished phasic electrodermal responses to stimuli, reducing the discriminative power of EDA-based scoring. Others may show paradoxical responses — strong electrodermal reactions to the physical sensation of the finger electrodes themselves, rather than to the psychological content of the questions.

A systematic review by Lydon, Healy, Reed, Mulhern, Hughes, and Goodwin (2016) in Developmental Neurorehabilitation examined 57 studies and found that individuals with autism responded differently from typically developing controls in 78.6% of sensory, 66.7% of social and emotional, and 71.4% of stressor stimulus classes [9]Verified A systematic review of physiological reactivity to stimuli in autism
Confirms individuals with autism responded differently from controls in 78.6% of sensory, 66.7% of social/emotional, and 71.4% of stressor stimulus classes across 57 reviewed studies. However, the review also noted variable and inconsistent findings across studies, suggesting the existence of physiological subtype responders within the ASD population.

Heart rate variability (HRV), reflecting vagal tone and parasympathetic regulation, is frequently atypical in ASD. Benevides and Lane (2015) conducted a comprehensive review of cardiac autonomic measures in the Journal of Autism and Developmental Disorders, synthesizing pediatric literature on ANS measures in both typical and ASD samples [10]Verified A Review of Cardiac Autonomic Measures: Considerations for Examination of Physiological Response in Children with Autism Spectrum Disorder
Confirms wide variability in ANS measures in ASD populations and provides foundation for cardiac ANS research methodology in autism. Autistic children have been found to show significantly lower tonic HRV compared to typically developing peers, suggesting less flexible autonomic regulation.

The cumulative impact of these autonomic differences is highly relevant for polygraph professionals. When baseline arousal is elevated, phasic responses are atypical, and normal patterns that examiners are trained to recognize do not follow expected trajectories, informed interpretation and appropriate accommodations become essential. Similar challenges arise with other conditions — our guide to bipolar disorder and polygraph testing and schizophrenia and lie detector tests cover related concerns.

Tactile Sensitivities and Polygraph Components

Sensory processing differences are recognized as a core diagnostic feature of ASD in the DSM-5 and present one of the most immediate practical challenges for polygraph testing. Research estimates that up to 90–95% of individuals with autism experience sensory processing differences [4]Verified Sensory Processing Disorder vs. Autism
Confirms approximately 90-95% of individuals with autism experience sensory processing differences, including hyper-sensitivity, hypo-sensitivity, or sensory-seeking behaviors. A large population-based study by Kirby et al. (2022) using CDC's ADDM Network data from over 25,000 autistic children found that 74% had documented sensory features [11]Verified Sensory features in autism: Findings from a large population-based surveillance system
Confirms 74% of over 25,000 autistic children in ADDM Network had documented sensory features; notes existing literature suggests 53%-94% prevalence range. The UK's National Autistic Society notes that existing research places the prevalence between 53% and 95% [12]Verified Autism and sensory processing
Confirms research suggests sensory processing differences in autism range between 53% and 95%.

The physical components of polygraph testing require direct contact with the examinee's body and pose distinct challenges:

Pneumograph tubes — Two elastic tubes positioned around the upper chest and abdomen can feel constricting, itchy, or intensely uncomfortable for autistic individuals with tactile hypersensitivity, generating continuous sensory distress throughout the examination.

Blood pressure cuff — Inflated to approximately 60 mmHg during data collection, the sustained squeezing sensation can be extremely distressing for sensory-sensitive individuals and may become the dominant focus of attention rather than the questions being asked.

Finger electrodes (EDA sensors) — Metal or gel-based electrodes attached to fingertips can produce sustained discomfort that elevates electrodermal readings independently of question content.

Movement sensors — Some modern setups include seat sensors or additional movement detectors, and the awareness of being physically monitored can increase self-consciousness and anxiety in individuals who already struggle with body awareness and proprioception.

Environmental Sensory Factors

Beyond the sensors themselves, the testing environment poses additional sensory challenges. Fluorescent lighting can produce an imperceptible flicker and hum that is highly distracting or distressing for autistic individuals with visual and auditory hypersensitivity. Ambient noise from air conditioning systems, building sounds, and the polygraph instrument can compete for attentional resources. The novelty of the testing room, unfamiliar smells, and the overall sensory profile of an unknown environment can trigger heightened arousal before testing even begins.

Critically, the physiological impact of sensory distress is indistinguishable from the physiological signatures of deception on a polygraph tracing. Increased sweating, elevated heart rate, respiratory disruptions, and blood pressure changes caused by sensory overload look identical on the chart to those caused by deception. This creates an inherent validity concern that examiners must address through environmental modifications and careful interpretation. This challenge is similar to those documented in studies of EyeDetect limitations, where neurological variability also affects testing outcomes.

Literal Language Processing

The language and communication differences associated with ASD have far-reaching implications for every phase of the polygraph examination. Polygraph testing is not merely a physiological measurement — it is fundamentally a psychological test that depends on the examinee understanding, processing, and responding to carefully constructed verbal stimuli.

One of the most well-documented features of ASD communication is a tendency toward literal interpretation of language. Consider a standard polygraph question such as: "Have you ever stolen anything from an employer?" A neurotypical examinee typically understands the intent as referring to significant theft. An autistic individual might generate a genuine physiological stress response while mentally cataloguing whether taking a pen home, using a company computer for personal email, or eating a coworker's labeled food constitutes "stealing." This internal process creates cognitive load and anxiety that manifests physiologically but has nothing to do with deception.

Similarly, temporal qualifiers ("ever," "recently," "in the last year") and scope qualifiers ("serious," "significant," "intentional") may be processed very differently by autistic examinees who think in precise, categorical terms. Understanding how pathological liars process questions differently provides an interesting comparison to how autistic individuals face the opposite challenge — an excess of honesty and precision rather than intentional deception.

Theory of Mind and Processing Speed

Many comparison question techniques rely on the examinee making social inferences about what the examiner is trying to determine. The comparison question test depends on truthful examinees being somewhat more concerned about comparison questions than relevant questions. This psychological dynamic requires the examinee to make inferences about the examiner's beliefs, the social stakes of different answers, and the implied meaning behind certain question types.

Differences in theory of mind — the ability to attribute mental states to others — are a well-established feature of ASD. An autistic examinee may not engage with comparison questions in the psychologically expected way, not because they lack the capacity for concern, but because they do not make the same social inferences about the question's purpose. The research team of Raskin & Kircher pioneered much of the foundational science behind comparison question techniques, and their work assumes neurotypical cognitive processing patterns.

Polygraph testing also follows a fairly rigid question cadence, with interstimulus intervals typically lasting 20–35 seconds. For autistic individuals who may require additional processing time for language comprehension, particularly under stress, this pace may be too rapid. The examinee may still be processing the meaning of one question when the next is asked, creating carry-over effects in the physiological data.

High Rates of Comorbid Anxiety

Anxiety disorders are one of the most common co-occurring conditions in ASD. Studies have found that overall prevalence rates for anxiety disorders in individuals with ASD range between 42% and 79%, with specific phobias being the most prevalent [5]Verified Prevalence of Anxiety in Autism Spectrum Disorders
Confirms anxiety disorders prevalence rates in ASD range between 42% and 79% for diagnosed anxiety disorders. A meta-analysis by van Steensel et al. (2011) concluded that about 40% of children with ASD had at least one comorbid diagnosed anxiety disorder [13]Verified Anxiety disorders in children and adolescents with autistic spectrum disorders: a meta-analysis
Confirms about 40% of children with ASD had at least one comorbid diagnosed anxiety disorder per van Steensel et al. meta-analysis. Research indicates that up to 84% of young autistic people experience clinically elevated anxiety symptoms [14]Verified Anxiety and Autism: The Impact of Anxiety on Daily Life
Confirms up to 84% of young autistic people experience clinically elevated anxiety; 42-79% meet diagnostic criteria for anxiety disorders. For autistic adults, the lifetime prevalence rate for anxiety was 42%, with social phobia and obsessive-compulsive disorder occurring most frequently [14]Verified Anxiety and Autism: The Impact of Anxiety on Daily Life
Confirms up to 84% of young autistic people experience clinically elevated anxiety; 42-79% meet diagnostic criteria for anxiety disorders.

This extraordinarily high comorbidity rate has direct and severe implications for polygraph testing. The comparison question test operates on the assumption that a truthful examinee's anxiety about comparison questions will exceed their anxiety about relevant questions. For an autistic individual with generalized anxiety disorder, baseline arousal may be so elevated that this differential modulation does not occur in a detectable way. This challenge parallels concerns documented in research on PTSD and polygraph testing, where elevated baseline arousal compromises differential reactivity.

Alexithymia and Interoception

Autistic individuals often experience and regulate emotions differently from neurotypical people. Research on interoception — the sense of internal bodily states — suggests that many autistic individuals have difficulty accurately perceiving and interpreting their own physiological states [7]Verified Alexithymia in Autism Spectrum Disorder
Confirms around 40-65% of people with ASD have high levels of alexithymia, citing Bird & Cook. This means the normal feedback loop between emotional experience and physiological regulation may function atypically.

Alexithymia plays a particularly important role. With approximately half of autistic individuals experiencing clinically significant alexithymia [6]Verified Investigating alexithymia in autism: A systematic review and meta-analysis
Confirms weighted mean prevalence of alexithymia in ASD at 49.93%, with individual studies ranging from 33.3% to 63%, many ASD examinees may have genuine difficulty reporting their own emotional states during the pre-test interview. A frontiers in Psychology review noted that alexithymia is "both a cause and consequence of autistic behavior" [15]Verified Alexithymia and Autism Spectrum Disorder: A Complex Relationship
Confirms approximately half of individuals with ASD estimated as having alexithymia; alexithymia is both a cause and consequence of autistic behavior, suggesting a complex bidirectional relationship that complicates the psychological assumptions underlying polygraph testing.

Research from EEG-based approaches to deception detection has shown that neurological variability significantly affects detection accuracy [16]Verified Neurocognitive Lie Detection Using EEG: Fast-Converging Deep Learning Models for Innocent and Guilty Classification in Neurological Disorders
Confirms deep learning framework achieved accuracy above 80% with sensitivity and specificity exceeding 75% while maintaining reliability despite neurological variability. Deep learning models for lie detection in neurological disorders have achieved accuracy above 80% while maintaining sensitivity and specificity exceeding 75%, demonstrating that optimized computational approaches can account for some neurological variability [16]Verified Neurocognitive Lie Detection Using EEG: Fast-Converging Deep Learning Models for Innocent and Guilty Classification in Neurological Disorders
Confirms deep learning framework achieved accuracy above 80% with sensitivity and specificity exceeding 75% while maintaining reliability despite neurological variability. These emerging technologies may eventually offer alternatives for populations where traditional polygraph has significant limitations.

The ADHD-ASD Overlap

According to the scientific literature, 50 to 70% of individuals with ASD also present with comorbid attention deficit hyperactivity disorder (ADHD) [17]Verified ASD and ADHD Comorbidity: What Are We Talking About?
Confirms 50-70% of individuals with ASD also present with comorbid ADHD. Other studies report an even broader range — a significant percentage of children with ASD seeking clinical services present with ADHD symptoms, with rates ranging between 37% and 85% across studies [18]Verified The Co-Occurrence of Autism and Attention Deficit Hyperactivity Disorder in Children
Confirms ADHD comorbidity rates in ASD ranging between 37% and 85% across studies; 30-50% of ASD individuals manifest ADHD symptoms. The DSM-5 now allows for dual diagnosis of ADHD and ASD, recognizing their frequent co-occurrence [19]Verified Unraveling the spectrum: overlap, distinctions, and nuances of ADHD and ASD in children
Confirms DSM-5 now allows dual ADHD/ASD diagnosis; co-occurring diagnosis is more severe and leads to lower quality of life.

This comorbidity is highly relevant for polygraph testing because ADHD medications — particularly stimulants like methylphenidate and amphetamines — increase sympathetic nervous system activity, potentially elevating baseline arousal. Examiners must be aware that stimulant medications may affect the cardiovascular and electrodermal channels monitored during testing.

Medications Commonly Used in ASD

Autistic individuals may take various medications that affect autonomic nervous system function and, consequently, polygraph readings:

SSRIs (e.g., fluoxetine, sertraline) — Commonly prescribed for comorbid anxiety and depression in ASD. SSRIs can affect heart rate variability and electrodermal activity.

Atypical antipsychotics (e.g., risperidone, aripiprazole) — FDA-approved for irritability associated with ASD. These medications have known effects on cardiovascular parameters including heart rate and blood pressure.

Stimulants (e.g., methylphenidate, amphetamines) — Used for comorbid ADHD. These directly increase sympathetic nervous system activity.

Anxiolytics (e.g., buspirone, benzodiazepines) — Used for anxiety management. These can suppress some autonomic responses that polygraph testing relies upon.

Examiners should always conduct a thorough medication review during the pre-test phase and consider how each medication might influence the physiological data. This is similar to the medication considerations discussed in our guide to polygraph testing in therapeutic settings.

Pre-Test Accommodations

Successful polygraph testing with autistic examinees requires proactive accommodations across every phase of the examination:

Collaborate with treating professionals — Before the examination, examiners should consult with the examinee's therapist, psychologist, or other treating professional to understand the individual's specific communication style, sensory sensitivities, anxiety triggers, and support needs.

Provide advance preparation materials — Send written descriptions of the testing process, photographs of the testing room and equipment, and a clear timeline of what will happen. Many autistic individuals benefit greatly from knowing exactly what to expect.

Extend the pre-test phase — Allow significantly more time for the pre-test interview. Autistic examinees may need additional time to process information, ask clarifying questions, and become comfortable with the examiner and environment.

Simplify question language — Use concrete, unambiguous language. Avoid idioms, metaphors, double negatives, and questions with implicit social assumptions. Test each question for literal interpretability.

Review questions in writing — Provide test questions in written form in advance, allowing the examinee to process them visually as well as aurally. This dual-channel approach supports comprehension for many autistic individuals.

Environmental and In-Test Modifications

Modify the testing environment — Reduce fluorescent lighting (use natural light or adjustable lamps), minimize ambient noise, ensure comfortable room temperature, and remove unnecessary sensory stimuli. Allow the examinee to visit the testing room beforehand.

Address sensor attachment carefully — Explain each sensor before placing it, allow the examinee to touch and examine the components, and check frequently for sensory distress during testing. Consider whether sensor placement can be modified to reduce discomfort.

Adjust question cadence — Increase interstimulus intervals beyond the standard 20–35 seconds if the examinee appears to need additional processing time. Monitor for signs of cognitive overload.

Allow breaks — Standard polygraph procedure can be adapted to include brief breaks between chart collections, especially for examinees showing signs of sensory overload or anxiety escalation.

Interpret data cautiously — Recognize that physiological patterns may not follow neurotypical expectations. Consider consulting with a psychophysiology specialist or ASD clinician when interpreting ambiguous results. These accommodation principles apply broadly to special populations, similar to considerations for addiction recovery testing.

Admissibility and Reliability Concerns

Polygraph evidence involving autistic examinees raises heightened legal and ethical concerns. The Americans with Disabilities Act (ADA) requires reasonable accommodations for individuals with disabilities, and this framework extends to testing situations. Attorneys challenging or defending polygraph results involving ASD individuals should consider:

Whether appropriate accommodations were provided during testing, whether the examiner had training or experience with ASD populations, whether the scoring methodology accounts for atypical autonomic baselines, and whether the examiner consulted with relevant clinical professionals.

The lack of a specific APA protocol for ASD examinations means that the standard of care is determined by the examiner's professional judgment and adherence to general best practices. This creates both flexibility and vulnerability — flexibility for examiners who implement thoughtful accommodations, and vulnerability for those who apply standard procedures without modification.

PCSOT and Supervision Contexts

Post-Conviction Sex Offender Testing (PCSOT) represents one of the most common contexts where autistic individuals encounter mandatory polygraph testing. In these supervision settings, polygraph is used as part of sex offender rehabilitation programs and ongoing monitoring.

When an individual under PCSOT supervision has an ASD diagnosis, the supervising officer, treatment provider, and polygraph examiner should collaborate to ensure testing accommodations are in place. False positive results — where a truthful autistic individual appears deceptive due to atypical physiological responses — carry particularly serious consequences in this context, potentially affecting treatment progress, supervision conditions, and liberty.

Informed consent takes on additional significance with ASD examinees. Level 3 ASD individuals may lack the capacity to provide meaningful informed consent, raising fundamental questions about whether polygraph testing is appropriate. For Level 1 and Level 2 individuals, consent processes should be adapted to ensure genuine understanding, potentially including visual supports, simplified language, and the involvement of a support person.

EEG-Based and Eye-Tracking Alternatives

Research into alternative deception detection methods may eventually offer more reliable options for ASD populations. EEG-based approaches have shown promise — cognitive load analysis of EEG beta spectrum activity has demonstrated that guilty participants show significantly higher beta power activity during deceptive responses to crime-relevant questions, while innocent participants show no such pattern [20]Verified Cognitive Load and EEG Beta Spectrum Analysis for Deception Detection
Confirms guilty participants showed significantly higher beta power activity during cognitively demanding deceptive responses while innocent participants showed no such pattern. This type of brain-based measurement may be less affected by the autonomic atypicalities present in ASD.

Deep learning models for neurocognitive lie detection have achieved accuracy above 80% with sensitivity and specificity exceeding 75%, while converging faster than conventional classifiers and maintaining reliability despite neurological variability [16]Verified Neurocognitive Lie Detection Using EEG: Fast-Converging Deep Learning Models for Innocent and Guilty Classification in Neurological Disorders
Confirms deep learning framework achieved accuracy above 80% with sensitivity and specificity exceeding 75% while maintaining reliability despite neurological variability. These computational approaches show potential for adapting to the physiological profiles of neurodiverse populations.

Eye-tracking technology has also shown diagnostic promise in related fields. Binocular eye tracking has achieved 90.2% sensitivity and 94.3% average accuracy in assessing paraphilic disorders [21]Verified Diagnostic accuracy of binocular eye tracking in the assessment of paraphilic disorders
Confirms binocular eye tracking achieved 90.2% sensitivity, 90.8% specificity, and 94.3% average accuracy, demonstrating eye-tracking as a viable physiological assessment method, suggesting that ocular measurements may provide alternative physiological channels for assessment. However, it is important to understand current EyeDetect limitations and the potential for false positives with innocent examinees.

While these technologies are not yet standard practice, they represent an exciting frontier. For current examinations, the most practical approach remains thoughtful accommodation of traditional polygraph methods combined with informed clinical judgment.

For Polygraph Examiners

1. Obtain ASD-specific training or continuing education before testing autistic examinees. 2. Always conduct a thorough pre-examination consultation with the examinee's treating clinician. 3. Perform a comprehensive medication review and understand how each medication may affect physiological readings. 4. Modify the testing environment to minimize sensory triggers before the examinee arrives. 5. Use concrete, literal question language and provide written copies of all test questions in advance. 6. Extend time allowances for every phase of the examination. 7. Document all accommodations provided and their rationale. 8. Interpret physiological data in the context of known ASD autonomic differences rather than assuming neurotypical baselines. 9. When results are ambiguous, err on the side of an inconclusive determination rather than a deceptive finding. 10. Consider whether polygraph testing is appropriate at all for the specific individual, particularly for those with Level 2 or Level 3 support needs.

For Therapists and Referring Clinicians

Therapists requesting polygraph testing for clients with ASD should actively prepare both the client and the examiner. Provide the examiner with detailed information about the client's communication style, sensory profile, anxiety triggers, medication regimen, and support needs. Consider using social stories or visual schedules to prepare the client for the testing experience.

When polygraph testing is part of a therapeutic framework, the results should always be interpreted within the broader clinical context. A single polygraph chart should never override clinical judgment, particularly when working with a population known to have atypical physiological responses. The therapeutic value of polygraph testing — promoting accountability and supporting honest disclosure — can still be achieved with appropriate accommodations, even when the numerical scoring may be less reliable.